William Guyer Corcept Therapeutics Inc (CORT) insider trading activity

William Guyer is Chief Development Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 1,235 shares of CORT, which is worth approximately $93,291. The most recent transaction as insider was on Dec 02, 2025, when has been sold 20,000 shares (Common Stock) at a price of $80.47 per share, resulting in proceeds of $1,609,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.24K

77.49% 3M change

77.49% 12M change

Total Value Held $93,291

William Guyer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Open market or private sale	$1,609,400 $80.47 p/Share	20,000 Reduced 94.18%	1,235 Common Stock
Dec 02 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 48.5%	21,235 Common Stock
Dec 02 2025	BUY Other acquisition or disposition	-	787 Added 38.92%	1,235 Common Stock
Dec 01 2025	BUY Grant, award, or other acquisition	$17,870 $39.89 p/Share	448 Added 50.0%	448 Common Stock
Nov 25 2025	SELL Open market or private sale	$364,050 $80.9 p/Share	4,500 Reduced 85.11%	787 Common Stock
Nov 05 2025	SELL Open market or private sale	$1,511,200 $75.56 p/Share	20,000 Reduced 79.09%	5,287 Common Stock
Nov 05 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 44.16%	25,287 Common Stock

Oct 07 2025	SELL Open market or private sale	$1,798,800 $89.94 p/Share	20,000 Reduced 79.09%	5,287 Common Stock
Oct 07 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 44.16%	25,287 Common Stock
Sep 19 2025	SELL Bona fide gift	-	200 Reduced 3.64%	5,287 Common Stock
Sep 02 2025	SELL Open market or private sale	$1,412,400 $70.62 p/Share	20,000 Reduced 78.47%	5,487 Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 43.97%	25,487 Common Stock
Aug 08 2025	SELL Open market or private sale	$2,512,452 $71.77 p/Share	35,007 Reduced 86.45%	5,487 Common Stock
Aug 08 2025	BUY Exercise of conversion of derivative security	$757,901 $21.65 p/Share	35,007 Added 46.37%	40,494 Common Stock
Aug 05 2025	SELL Open market or private sale	$1,004 $71.77 p/Share	14 Reduced 0.25%	5,487 Common Stock
Aug 05 2025	BUY Exercise of conversion of derivative security	$303 $21.65 p/Share	14 Added 0.25%	5,501 Common Stock
Jul 18 2025	SELL Open market or private sale	$36,720 $73.44 p/Share	500 Reduced 8.35%	5,487 Common Stock
Jul 18 2025	BUY Exercise of conversion of derivative security	$10,825 $21.65 p/Share	500 Added 7.71%	5,987 Common Stock
Jul 17 2025	SELL Open market or private sale	$321,768 $73.48 p/Share	4,379 Reduced 44.38%	5,487 Common Stock
Jul 17 2025	BUY Exercise of conversion of derivative security	$94,805 $21.65 p/Share	4,379 Added 30.74%	9,866 Common Stock
Jul 01 2025	SELL Open market or private sale	$7,350 $73.5 p/Share	100 Reduced 1.79%	5,487 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$2,165 $21.65 p/Share	100 Added 1.76%	5,587 Common Stock
Jun 10 2025	SELL Open market or private sale	$1,451,200 $72.56 p/Share	20,000 Reduced 78.47%	5,487 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	$433,000 $21.65 p/Share	20,000 Added 43.97%	25,487 Common Stock
May 16 2025	SELL Open market or private sale	$2,392,872 $74.17 p/Share	32,262 Reduced 85.46%	5,487 Common Stock

William Guyer

Chief Development Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account